Collectively, these results show a clear response of CLL cells to BCR triggering, but no significant difference in stimulation efficiency between mutated (N = 11) and unmutated (N = 10) cases, measured by FOS or MYC expression. The gene discussed is FOS; the disease is B-cell chronic lymphocytic leukemia.